Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| INTERLEUKIN GENETICS INC | 20,120,724 | reported | 29 Jul 2016 | tx 4+79,979,378 |
| Millennial Media Inc. | 8,196,614 | reported | 29 Oct 2012 | tx 4+9,794,401−11,392,188 |
| Epizyme, Inc. | 5,854,351 | reported | 12 Jan 2016 | tx 18+7,564,725−18,202,621 |
| AEROHIVE NETWORKS, INC | 4,673,589 | reported | 02 Apr 2014 | tx 3+4,653,589−4,653,589 |
| ARDELYX, INC. | 2,665,520 | reported | 18 Jul 2016 | tx 4+2,527,301 |
| Mirna Therapeutics, Inc. | 2,114,375 | reported | 06 Oct 2015 | tx 7+2,971,517−1,825,209 |
| BOX INC | 2,091,457 | reported | 28 Jan 2015 | tx 5+4,020,134−4,020,134 |
| Tracon Pharmaceuticals, Inc. | 1,888,474 | reported | 04 Feb 2015 | tx 3+1,888,474−5,373,396 |
| TESARO, Inc. | 710,429 | reported | 18 Mar 2016 | tx 20+12,947,501−13,060,532 |
| Avalo Therapeutics, Inc. | 594,245 | reported | 20 Oct 2015 | tx 2+594,245−16,638,880 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 31 Oct 2016 | EXERCISE | Ra Pharmaceuticals, Inc. | 80,658 | 0.07 USD | |
| 31 Oct 2016 | SALE | Ra Pharmaceuticals, Inc. | 435 | 13.00 USD | |
| 31 Oct 2016 | PURCHASE | Ra Pharmaceuticals, Inc. | 338,462 | 13.00 USD | |
| 31 Oct 2016 | CONVERSION | Ra Pharmaceuticals, Inc. | 1,778,227 | — | |
| 31 Oct 2016 | CONVERSION | Ra Pharmaceuticals, Inc. | 669,951 | — | |
| 31 Oct 2016 | CONVERSION | Ra Pharmaceuticals, Inc. | 623,210 | — | |
| 31 Oct 2016 | EXERCISE | Ra Pharmaceuticals, Inc. | 80,658 | 0.00 USD | deriv |
| 31 Oct 2016 | CONVERSION | Ra Pharmaceuticals, Inc. | 4,689,657 | 0.00 USD | deriv |
| 31 Oct 2016 | CONVERSION | Ra Pharmaceuticals, Inc. | 4,362,472 | 0.00 USD | deriv |
| 31 Oct 2016 | CONVERSION | Ra Pharmaceuticals, Inc. | 12,447,605 | 0.00 USD | deriv |
| 21 Sept 2016 | PURCHASE | Roka BioScience, Inc. | 4,000 | — | deriv |
| 21 Sept 2016 | PURCHASE | Roka BioScience, Inc. | 5,714,286 | — | deriv |
| 29 Jul 2016 | PURCHASE | INTERLEUKIN GENETICS INC | 20,120,724 | 0.10 USD | |
| 29 Jul 2016 | PURCHASE | INTERLEUKIN GENETICS INC | 20,120,724 | 0.00 USD | deriv |
| 18 Jul 2016 | PURCHASE | ARDELYX, INC. | 763,650 | 8.73 USD | |
| 18 Jul 2016 | PURCHASE | ARDELYX, INC. | 763,651 | 8.73 USD | |
| 18 Mar 2016 | PURCHASE | TESARO, Inc. | 710,429 | 35.19 USD | |
| 18 Mar 2016 | PURCHASE | TESARO, Inc. | 710,429 | 35.19 USD | |
| 13 Jan 2016 | PURCHASE | ARDELYX, INC. | 500,000 | 10.00 USD | |
| 13 Jan 2016 | PURCHASE | ARDELYX, INC. | 500,000 | 10.00 USD | |
| 12 Jan 2016 | PURCHASE | Epizyme, Inc. | 1,111,111 | 9.00 USD | |
| 20 Oct 2015 | CONVERSION | Avalo Therapeutics, Inc. | 594,245 | — | |
| 20 Oct 2015 | CONVERSION | Avalo Therapeutics, Inc. | 16,638,880 | 0.00 USD | deriv |
| 05 Oct 2015 | CONVERSION | Mirna Therapeutics, Inc. | 1,241,650 | — | |
| 06 Oct 2015 | OTHER | Mirna Therapeutics, Inc. | 257,516 | 0.00 USD |